The findings revealed that primary breast cancer, colon cancer, ovarian cancer, clear cell RCC, UCEC, lung cancer, head and neck squamous carcinoma, and glioblastoma exhibited higher levels of the total PRKCSH protein. This evidence concerns the gene PRKCSH and lung carcinoma.